Evan S. Cole, PhD, Ellen DiDomenico, MS, Sherri Green, PhD, MSW, LCSW, Susan K. R. Heil, PhD, MS, Tandrea Hilliard, PhD, MPH, Sarah E. Mossburg, PhD, MS, Andrew L. Sussman, PhD, Jack Warwick, MPH, John M. Westfall, MD, MPH, Linda Zittleman, MSPH and Julie G. Salvador, PhD share their own thoughts around their SAj commentary published this last February.
“There are many barriers that primary care providers face to offer opioid use disorder treatment using medications such as buprenorphine and naltrexone in rural settings. This manuscript argues that training and support for the entire clinic using a broad menu of resources is essential, but is not addressed by the DATA 2000 waiver requirement. The manuscript provides clear guidance, based on data across five research studies, regarding best approaches for engaging and supporting rural primary care providers to start MOUD treatment and help address the OUD crisis nationally. Our commentary is unique as it summarizes cross-cutting themes from grantees in five different states, working with a broad mix of clinic types (e.g., solo practice vs rural health system), thus enhancing the generalizability that our findings might offer to providers, payer, and policymakers.”
Read this article now here and follow SAj on twitter to stay up to date with new publications!